Log in to WRAL.com with one click using your favorite social network:
OR
Log in using your WRAL.com account:



Wrong email/password combination.

Forgot password?

Register with WRAL.com using your favorite social network:
OR
Register for a WRAL.com account using our web form.

Login Options

3:36 p.m. • 2-12-12

Weather Forecast for Raleigh

  • Mon: Partly Cloudy.
    • Hi: 50° F
  • Tue: Rain.
    • Hi: 53° F
  • Wed: Partly Cloudy.
    • Hi: 57° F

Other Locations

> 7 Day Forecast

Doppler Image

Marketplace Links

Social Links

Main Menu

LabCorp Licenses Ovarian Cancer Test From Yale


e-mail print friendly

Women may soon have a new weapon in the fight to detect the deadly killer ovarian cancer.

Laboratory Corporation of America said Thursday it had licensed a new blood testing technology for ovarian cancer from Yale University. The test is still under development.

Terms of the contract were not disclosed.

Ovarian cancer is the fourth most common cause of cancer in women and is the leading cause of gynecologic death.

"Ovarian cancer is one of the most difficult cancers to detect, especially in the earliest stages when it is more treatable," said Myla Lai-Goldman, executive vice president, chief scientific officer and medical director of LabCorp. "Consistent with our oncology strategy to fulfill unmet medical testing needs, LabCorp continues to dedicate resources to identifying and commercializing tests to help discriminate earlier between disease-free and cancer patients."

e-mail print friendly

0 Comments


WRAL.com welcomes your comments on this story. All comments are moderated prior to publication based on our posting guidelines. Please review them prior to posting and if your message is not approved.

View Comments 0 COMMENTS

This story is closed for comments. Comments on WRAL.com news stories are accepted and moderated between the hours of 8 a.m. and 8 p.m. Monday through Friday.

View Comments 0 COMMENTS
Report It

Multimedia

Click Here